These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1884990)

  • 1. The role of the serine protease active site in the mode of action of epidermolytic toxin of Staphylococcus aureus.
    Redpath MB; Foster TJ; Bailey CJ
    FEMS Microbiol Lett; 1991 Jun; 65(2):151-5. PubMed ID: 1884990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The epidermolytic (exfoliative) toxins of Staphylococcus aureus.
    Bailey CJ; Lockhart BP; Redpath MB; Smith TP
    Med Microbiol Immunol; 1995 Aug; 184(2):53-61. PubMed ID: 7500911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The reactive serine residue of epidermolytic toxin A.
    Bailey CJ; Smith TP
    Biochem J; 1990 Jul; 269(2):535-7. PubMed ID: 2117445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidermolytic toxins are serine proteases.
    Dancer SJ; Garratt R; Saldanha J; Jhoti H; Evans R
    FEBS Lett; 1990 Jul; 268(1):129-32. PubMed ID: 2384148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel features of serine protease active sites and specificity pockets: sequence analysis and modelling studies of glutamate-specific endopeptidases and epidermolytic toxins.
    Barbosa JA; Saldanha JW; Garratt RC
    Protein Eng; 1996 Jul; 9(7):591-601. PubMed ID: 8844831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structure of Staphylococcus aureus epidermolytic toxin A, an atypic serine protease, at 1.7 A resolution.
    Cavarelli J; Prévost G; Bourguet W; Moulinier L; Chevrier B; Delagoutte B; Bilwes A; Mourey L; Rifai S; Piémont Y; Moras D
    Structure; 1997 Jun; 5(6):813-24. PubMed ID: 9261066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional evidence that the Ser-195 residue of staphylococcal exfoliative toxin A is essential for biological activity.
    Prévost G; Rifai S; Chaix ML; Piémont Y
    Infect Immun; 1991 Sep; 59(9):3337-9. PubMed ID: 1908832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of the superantigen staphylococcal exfoliative toxin A (ETA).
    Rago JV; Vath GM; Bohach GA; Ohlendorf DH; Schlievert PM
    J Immunol; 2000 Feb; 164(4):2207-13. PubMed ID: 10657676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the mechanism of action of the exfoliative toxins of Staphylococcus aureus.
    Ladhani S
    FEMS Immunol Med Microbiol; 2003 Nov; 39(2):181-9. PubMed ID: 14625102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleotide sequence of the epidermolytic toxin A gene of Staphylococcus aureus.
    O'Toole PW; Foster TJ
    J Bacteriol; 1987 Sep; 169(9):3910-5. PubMed ID: 3040667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The crystal structure of exfoliative toxin B: a superantigen with enzymatic activity.
    Vath GM; Earhart CA; Monie DD; Iandolo JJ; Schlievert PM; Ohlendorf DH
    Biochemistry; 1999 Aug; 38(32):10239-46. PubMed ID: 10441117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The structure of a universally employed enzyme: V8 protease from Staphylococcus aureus.
    Prasad L; Leduc Y; Hayakawa K; Delbaere LT
    Acta Crystallogr D Biol Crystallogr; 2004 Feb; 60(Pt 2):256-9. PubMed ID: 14747701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New evidence that the Tyr-157 and Tyr-159 residues of staphylococcal exfoliative toxin B are essential for its toxicity.
    Sakurai S; Suzuki H; Saito S; Konishi Y; Machida K; Kohno M
    Microbiol Immunol; 1998; 42(12):829-36. PubMed ID: 10037217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental studies on the mechanism of the action of staphylococcal epidermolytic toxin A utilizing recombinant toxin].
    Inaoki M
    Nihon Hifuka Gakkai Zasshi; 1990 Dec; 100(14):1405-14. PubMed ID: 2082042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural similarities and differences in Staphylococcus aureus exfoliative toxins A and B as revealed by their crystal structures.
    Papageorgiou AC; Plano LR; Collins CM; Acharya KR
    Protein Sci; 2000 Mar; 9(3):610-8. PubMed ID: 10752623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of Staphylococcus aureus exfoliative toxin D-like protein: Structural basis for the high specificity of exfoliative toxins.
    Mariutti RB; Souza TA; Ullah A; Caruso IP; de Moraes FR; Zanphorlin LM; Tartaglia NR; Seyffert N; Azevedo VA; Le Loir Y; Murakami MT; Arni RK
    Biochem Biophys Res Commun; 2015 Nov; 467(1):171-7. PubMed ID: 26299923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylococcal scalded skin syndrome: exfoliative toxin A (ETA) induces serine protease activity when combined with A431 cells.
    Ladhani S; Poston SM; Joannou CL; Evans RW
    Acta Paediatr; 1999 Jul; 88(7):776-9. PubMed ID: 10447140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assays for epidermolytic toxin of Staphylococcus aureus.
    de Azavedo JC; Arbuthnott JP
    Methods Enzymol; 1988; 165():333-8. PubMed ID: 3148097
    [No Abstract]   [Full Text] [Related]  

  • 19. The esterolytic activity of epidermolytic toxins.
    Bailey CJ; Redpath MB
    Biochem J; 1992 May; 284 ( Pt 1)(Pt 1):177-80. PubMed ID: 1599396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification of epidermolytic toxin of Staphylococcus aureus.
    de Azavedo JC; Bailey CJ; Arbuthnott JP
    Methods Enzymol; 1988; 165():32-6. PubMed ID: 3231110
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.